SCHEMBL9697110

SCHEMBL9697110

COP(=O)(C#Cc1c(C(C)C)c2n(c1-c1ccc(F)cc1)CCCC2)C[C@H](CC(=O)O)O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.31
KCNK3 O14649 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9696802 0.88 KCNK3 (0.31) KCNK3
SCHEMBL9781040 0.84 HMGCR (0.30)
SCHEMBL9853863 0.84 HMGCR (0.30)
SCHEMBL9696593 0.84 KMT2A (0.37) KMT2A
SCHEMBL9697116 0.83 KMT2A (0.31) KMT2A
SCHEMBL8952910 0.81 HMGCR (0.40)
SCHEMBL9441809 0.80 HMGCR (0.40)
SCHEMBL9655519 0.80 HMGCR (0.35)
SCHEMBL8952852 0.78
SCHEMBL8952835 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124453-A Treatment of corresponding aldehyde with lithium bis(tri-methylsilyl)amide E. R. SQUIBB & SONS, INC. (US) 1992-06-23 US disclosed
EP-0444532-A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method E.R. SQUIBB & SONS, INC. (US) 1991-09-04 EP disclosed
US-5025000-A Anticholesterol, antilipemic agents E. R. SQUIBB & SONS, INC. (US) 1991-06-18 US disclosed